Area of Focus: Immunology

P3 Therapeutic (P3T) is a pre-clinical stage biotech company incorporated in Croatia. P3T was founded in 2024. to enhance patient outcomes and quality of life by creating precision, small chemical molecules (SCM) for chronic inflammation in spondyloarthritis (SpA) and related Immune-mediated diseases (IMID’s).